Misplaced Pages

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 16:12, 21 October 2011 (Updating {{drugbox}} (changes to verified fields - updated 'ChEBI_Ref', 'CAS_number_Ref') per Chem/Drugbox validation (report errors or bugs)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Gadoversetamide

Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Routes of administration	Intravenous
ATC code	V08CA06 (WHO)
Pharmacokinetic data
Protein binding	Nil
Metabolism	Nil
Elimination half-life	80 to 120 minutes
Excretion	Renal
Identifiers
CAS Number	131069-91-5
PubChem CID	6435809
DrugBank	APRD00993
ChemSpider	392041
UNII	RLM74T3Z9D
KEGG	D01646
ChEMBL	ChEMBL1200457
CompTox Dashboard (EPA)	DTXSID10156865
Chemical and physical data
Formula	C20H34GdN5O10
Molar mass	661.77 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES .O=C(NCCOC)CN(CC()=O)CCN(CC()=O)CCN(CC(=O)NCCOC)CC()=O
InChI InChI=1S/C20H37N5O10.Gd/c1-34-9-3-21-16(26)11-24(14-19(30)31)7-5-23(13-18(28)29)6-8-25(15-20(32)33)12-17(27)22-4-10-35-2;/h3-15H2,1-2H3,(H,21,26)(H,22,27)(H,28,29)(H,30,31)(H,32,33);/q;+3/p-3 Key:HBEAOBRDTOXWRZ-UHFFFAOYSA-K
(what is this?)  (verify)

Gadoversetamide is a gadolinium-based MRI contrast agent, particularly for imaging of the brain, spine and liver. It is marketed under the trade name OptiMARK.

Notes

1. "Gadoversetamide Drug Information". Drugs.com. 2000-03-20. Retrieved 2007-03-23.

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Gadolinium compounds
• MRI contrast agents
• Pharmacology stubs